Antibacterial composite medicine containing sulbenicillin sodium and clavulanic acid compound

A technology of sulfobenicillin sodium and clavulanate potassium, which is applied in the field of antibacterial combination drugs, can solve the problems of increasing the dosage, increasing the economic burden, and being difficult to achieve bactericidal effect, and reducing the dosage of the drug and reducing the economic burden. Effect

Inactive Publication Date: 2011-10-12
HUNAN ERKANG XIANGYAO PHARMA
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, with the widespread application, the resistance of bacteria to sulbenicillin sodium has increased, and it is difficult to achieve the previous bactericidal effect w...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibacterial composite medicine containing sulbenicillin sodium and clavulanic acid compound
  • Antibacterial composite medicine containing sulbenicillin sodium and clavulanic acid compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-6

[0015] The drugs and bacterial strains used in the following examples and comparative examples are all commercially available.

[0016] In each of the following examples and comparative examples, each material is mixed by weight ratio.

[0017] MIC refers to the minimum concentration of antibacterial combination drugs that can inhibit the growth of bacteria in the medium in vitro tests; MIC 50 (50% minimum inhibitory concentration), is the minimum inhibitory concentration of 50%, under the same experimental conditions, MIC 50 The smaller the value, the better the antibacterial effect of the drug, and the MIC unit is ug / g.

[0018] Embodiment 1-6 and comparative example 1-2 all operate and record MIC according to the experiment of measuring minimum inhibitory concentration of medicine (abbreviation MIC) in common microorganism test 50 Listed in Table 1.

[0019] Table 1 lists the comparative examples and the MICs of different antimicrobial drug combinations 50 ; The MIC of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an antibacterial composite medicine containing sulbenicillin sodium and a clavulanic acid compound, a freeze-dried powder injection containing the antibacterial medicinal composition. The medicine consists of sulbenicillin sodium and a clavulanic acid compound, which are in a weight ratio of (2-7):1. Under the same antibacterial condition, the antibacterial composite medicine provided by the invention reduces medicine dose, economic load of patients and production cost.

Description

technical field [0001] The invention relates to an antibacterial combination drug, in particular to an antibacterial combination drug containing sulbenicillin sodium and its freeze-dried powder injection. Background technique [0002] In recent years, sulbenicillin sodium has been widely used as an antibiotic in clinic. However, with the wide application, the resistance of bacteria to sulbenicillin sodium has increased, and it is difficult to achieve the previous bactericidal effect by increasing the dosage. The use of large doses of sulbenicillin sodium not only increases the economic burden of patients, but also further enhances the drug resistance of bacteria. In order to address the increasing drug resistance, there is an urgent need to develop a new combination of antibacterial drugs. Contents of the invention [0003] The object of the present invention is to provide an antibacterial combination drug containing sulbenicillin sodium and clavulanic acid compounds. Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/43A61K31/424A61K9/19A61P31/04
Inventor 帅放文王向峰章家伟
Owner HUNAN ERKANG XIANGYAO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products